Skip to content

Author

Ricardo Romero-Guevara

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Rimonabant reveals reward- and anxiety-related behavioral effects of N-arachidonoyl dopamine (N-ADA) in mice.

The endovanilloid N-arachidonoyl dopamine (N-ADA) is a lipid mediator associated with nociception and inflammation, but its effects on reward and anxiety remain unclear. We examined the behavioral impact of subacute N-ADA pre-exposure on conditioned place preference (CPP) and anxiety-like behavior in the circular open-...

Oliver A. Colis-Arenas, Katya Ch Navarro-Montellano, Carlos H. López-Lariz et al. · 0 citations
Review Open access Jul 2026

Emerging roles of cannabinoid pathways in renal injury and repair

Chronic kidney disease (CKD) is a significant health problem around the world. It can progress towards end-stage renal disease (ESRD), in which the current therapeutic options are dialysis and kidney transplant, which have several challenges in therapy compliance and finding a donor. There is a crosstalk between high b...

Ricardo Romero-Guevara, Sergio Guzmán-Rodríguez, B. Marichal-Cancino · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.